Medication info
Terriptin M Sustained-release Tablet 20/1000 mg

Terriptin M Sustained-release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletTeneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
Pink oval-shaped sustained-release film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202202704 · Approved 2022.07.01 · Insurance code 642405050

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take two tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from concomitant therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin that the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because changes may affect blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication helps control blood glucose levels in patients with type 2 diabetes by taking Teneligliptin and Metformin together. It is suitable for patients who are also following diet and exercise therapy, and is used to effectively improve blood glucose levels.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take two tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from concomitant therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin that the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because changes may affect blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used to treat diabetes and plays a role in lowering blood glucose levels. It may rarely cause a serious condition called lactic acidosis during its use, which can become dangerous due to excessive buildup of lactate in the body, so caution is necessary. It is particularly important that patients with poor kidney function, heart disease, or liver dysfunction do not use this medication. This medication should be discontinued at least 48 hours before exams using iodine-based contrast agents, and should be resumed only after normal kidney function is confirmed post-examination. Women who are pregnant or may become pregnant should avoid taking this medication, and breastfeeding mothers should consult with a physician. When used in combination with other diabetes medications, hypoglycemic symptoms may occur; therefore, patients should be well-informed about the symptoms and how to manage them. Additionally, it is important to regularly monitor kidney function and conduct blood tests during the period of taking this medication to check for any abnormalities. Excessive alcohol consumption may increase the risk of lactic acidosis when taking this medication, so alcohol should be avoided. This medication may cause side effects such as gastrointestinal disturbances, liver function abnormalities, pneumonia, skin rashes, etc.; therefore, if any abnormal manifestations occur, it is vital to consult a physician immediately. Elderly patients may experience decreased kidney function, and thus, dosage adjustments and regular testing are needed. If a surgery is planned, this medication should be discontinued 48 hours before the surgery, and resumed only after normal kidney function is confirmed post-surgery. This medication may interact with certain other drugs; therefore, if taking other medications, it is essential to inform the doctor or pharmacist. Lastly, this medication is not used in children as its safety and efficacy have not been established.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus
  • acute pancreatitis
  • dizziness
Show 132 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • increased GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • occult hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • increased serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • myasthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood glucose
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc prolapse
  • intervertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculi
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • gastrointestinal motility reduction
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • hemorrhage
  • increased blood sugar
  • abnormal phlegm
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • hearing loss
  • endolymphatic hydrops
  • ovarian cysts
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the efficacy of the medication for safe use.

Appearance and packaging

Appearance

Pink oval-shaped sustained-release film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.